Investing.com -- ProPhase Labs Inc (NASDAQ:PRPH) stock surged 75.2% in premarket trading Friday after the company announced a ...
DOYLESTOWN, PA--(Marketwire - Nov 27, 2012) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) announced today that on November 26, 2012, it entered into an Investment Agreement (the ...
DOYLESTOWN, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the “Company” or “ProPhase”), today ...
ProPhase Labs, Inc. PRPH shares soared 11.2% in the last trading session to close at $8.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important. Crown Medical Achieves Final Hurdle.
Visit a quote page and your recently viewed tickers will be displayed here.
ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...